Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia

Authors: Elena D’Alcamo, V. Agrigento, L. Pitrolo, S. Sclafani, R. Barone, G. Calvaruso, V. Buffa, A. Maggio

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Congenital dyserythropoietic anemia type I is an autosomal recessive disorder associated with macrocytic anemia, ineffective erythropoiesis, iron overloading and characterized by abnormal chromatin ultrastructure in erythroblasts such as internuclear chromatin bridges, spongy heterochromatin and invagination of the nuclear membrane. A 58-year-old Causasian man with chronic hemolytic anemia, heterozygous for β + -globin IVS1, nt110 G>A mutation (causing abnormal alpha:beta globin chain ratio) showed clinical, laboratory and hematological features suggesting diagnosis of CDA1. Sequence analysis of CDA-related genes revealed compound heterozygosity for two novel mutations in the CDAN1 gene: a frameshift mutation 3367 del 4 (TTAG) in exon 25 and a missense mutation c.1811 G>T in exon 11 causing an aminoacid change from glycine to valine at codon 565 (G565V). One of the propositus’ brothers showed the same gene mutations. As the CDA1 can mimic thalassemia, a frequent misdiagnosis is possible especially in countries where the prevalence of thalassemia is high. A strong clinical suspicion in patients who do not reveal a clear genetic basis for presumed thalassemia may help clinch the correct diagnosis.
Literature
1.
go back to reference Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H et al (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71:1467–1474CrossRefPubMedPubMedCentral Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H et al (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71:1467–1474CrossRefPubMedPubMedCentral
2.
go back to reference Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936–940CrossRefPubMed Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936–940CrossRefPubMed
3.
go back to reference Liljeholm M, Irvine AF, Wikberg AL, Norberg A, Month S, Sandström H et al (2013) Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. Blood 121(23):4791–4799CrossRefPubMed Liljeholm M, Irvine AF, Wikberg AL, Norberg A, Month S, Sandström H et al (2013) Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. Blood 121(23):4791–4799CrossRefPubMed
4.
go back to reference Wickramasinghe SN (1997) Dyserythropoiesis and congenital dyserythropoietic anemias. Br J Haematol 98:785–797CrossRefPubMed Wickramasinghe SN (1997) Dyserythropoiesis and congenital dyserythropoietic anemias. Br J Haematol 98:785–797CrossRefPubMed
5.
go back to reference Tamary H, Shalev H, Luria D, Shaft D, Zoldan M, Shalmon L et al (1996) Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 87:1763–1770PubMed Tamary H, Shalev H, Luria D, Shaft D, Zoldan M, Shalmon L et al (1996) Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 87:1763–1770PubMed
6.
7.
go back to reference D’Alcamo E, Agrigento V, Sclafani S, Vitrano A, Cuccia L, Maggio A, Perrotta S, Capra M, Rigano P (2011) Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Haematologica, 125(3):136–140, 1421–96621 D’Alcamo E, Agrigento V, Sclafani S, Vitrano A, Cuccia L, Maggio A, Perrotta S, Capra M, Rigano P (2011) Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Haematologica, 125(3):136–140, 1421–96621
8.
go back to reference Heimpel H et al (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 107:334–340CrossRefPubMed Heimpel H et al (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 107:334–340CrossRefPubMed
9.
go back to reference Dukka S, King MJ, Hill QA (2014) The diagnostic challenge of congenital dyserythropoietic anaemia: two cases of ‘CDA type II’. J Clin Pathol 67(4):367–369CrossRefPubMed Dukka S, King MJ, Hill QA (2014) The diagnostic challenge of congenital dyserythropoietic anaemia: two cases of ‘CDA type II’. J Clin Pathol 67(4):367–369CrossRefPubMed
10.
go back to reference Renella R, Roberts NA, Brown JM, De Gobbi M, Bird LE, Hassanali T et al (2011) Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1 alpha localization in erythroblasts. Blood 117:6928–6938CrossRefPubMed Renella R, Roberts NA, Brown JM, De Gobbi M, Bird LE, Hassanali T et al (2011) Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1 alpha localization in erythroblasts. Blood 117:6928–6938CrossRefPubMed
11.
go back to reference Ask K, Jasencakova Z, Menard P, Feng Y, Almouzni G, Groth A (2012) Codanin-1 mutated in the anaemic disease CDA1 regulates Asf1 function in S-phase histone supply. EMBO J 31(8):2013–2022CrossRefPubMedPubMedCentral Ask K, Jasencakova Z, Menard P, Feng Y, Almouzni G, Groth A (2012) Codanin-1 mutated in the anaemic disease CDA1 regulates Asf1 function in S-phase histone supply. EMBO J 31(8):2013–2022CrossRefPubMedPubMedCentral
12.
go back to reference Galanello R, Perseu L, Satta S, De Martis FR, Campus S (2011) Phenotype–genotype correlation in beta-Thalassemia. Thalassemia Rep 1(s2):e6 Galanello R, Perseu L, Satta S, De Martis FR, Campus S (2011) Phenotype–genotype correlation in beta-Thalassemia. Thalassemia Rep 1(s2):e6
Metadata
Title
New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia
Authors
Elena D’Alcamo
V. Agrigento
L. Pitrolo
S. Sclafani
R. Barone
G. Calvaruso
V. Buffa
A. Maggio
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0633-z

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine